| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |